Related Experiment Video
Updated: Jan 3, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
Palliative care in 9 children with neurodegeneration with brain iron accumulation
Tomasz Dangel1, Tomasz Kmieć2, Artur Januszaniec3
1Warsaw Hospice for Children Foundation, Agatowa 10, 03-680, Warsaw, Poland. dangel@hospicjum.waw.pl.
Insights
Pediatric palliative home care effectively managed neurodegeneration with brain iron accumulation (NBIA) symptoms, improving quality of life for children and families. Botulinum toxin and ketogenic diets were key interventions.
Area of Science:
- Pediatric Neurology
- Palliative Care
- Rare Diseases
Background:
- Neurodegeneration with Brain Iron Accumulation (NBIA) presents significant challenges for affected children and their families.
- Effective management strategies for NBIA are crucial to improve patient quality of life and provide family support.
Purpose of the Study:
- To evaluate the efficacy and outcomes of pediatric palliative home care for children with NBIA.
- To assess the impact of multidisciplinary interventions, including botulinum toxin injections and dietary management, on patient well-being.
- To gauge parental satisfaction with the provided palliative home care services.
Main Methods:
- A multidisciplinary team provided home-based palliative care to 9 NBIA patients.
- Skeletal health was assessed using densitometry.
- Botulinum toxin was administered for spasticity and dystonia management.
- Parental satisfaction was evaluated via a custom questionnaire.
Main Results:
- Palliative home care averaged 1569 days, with a median patient age of 9 years at admission.
- Botulinum toxin injections reduced spasticity, pain, and deformities, while a ketogenic diet increased body mass in most patients.
- Despite reduced bone density, palliative care was positively evaluated by parents.
- Median age at death was 11 years for 6 patients.
Conclusions:
- Palliative home care represents an optimal treatment approach for children diagnosed with NBIA.
- Multidisciplinary interventions can significantly alleviate symptoms and improve the quality of life for NBIA patients.
- Home-based care facilitates comprehensive management and support for children with rare neurodegenerative conditions.
Aim:
Evaluation of pediatric palliative home care of families with children suffering from neurodegeneration with brain iron accumulation (NBIA) and their parents.
Material And Methods:
The children were treated at home by a multidisciplinary team. Densitometry was used to evaluate the condition of the skeletal system. Botulinum toxin was injected into the muscles in doses between 22 and 50 units/kg. The quality of palliative care was assessed on the basis of a specially designed questionnaire for parents.
Results:
The observations were performed on a group of 9 patients with NBIA. On admission, the median age of patients was 9 years (7-14). The average time of palliative home care was 1569 days (34 days-17 years). The median age at death (6 patients) was 11 years (7-15). The botulinum toxin injections gave the following results: reduction of spasticity and dystonia, reduction of spine and chest deformation, relief of pain and suffering, facilitation of rehabilitation and nursing, prevention of permanent contractures, and reduction of excessive salivation. Bone mineral density and bone strength index were reduced. Two patients experienced pathological fracture of the femur. The body mass index at admission varied between 9.8 and 14.9. In 7 cases, introduction of a ketogenic diet resulted in the increase of body mass and height. The ketogenic diet did not worsen the neurological symptoms. The parents positively evaluated the quality of care.
Conclusion:
Palliative home care is the optimal form of treatment for children with NBIA.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Continuing Care
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

